TCG Crossover Management, LLC Q3 2023 Filing
Filed November 14, 2023
Portfolio Value
$679.1T
Holdings
26
Report Date
Q3 2023
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | GPCRSTRUCTURE THERAPEUTICS INC | 1,502,747 | $75.8T | 11.16% | |
| 2 | COGTCOGENT BIOSCIENCES INC | 5,631,042 | $54.9T | 8.08% | |
| 3 | GONGERON CORP | 23,375,839 | $49.6T | 7.30% | |
| 4 | ANTXAN2 Therapeutics, Inc. | 2,678,209 | $43.1T | 6.34% | |
| 5 | YB4PSAVARA INC. | 10,000,000 | $37.8T | 5.57% | |
| 6 | TSHATAYSHA GENE THERAPIES, INC. | 11,111,111 | $35.1T | 5.17% | |
| 7 | KALVKALVISTA PHARMACEUTICALS, INC | 3,395,495 | $32.7T | 4.81% | |
| 8 | INBXUSDINHIBRX,INC | 1,750,387 | $32.1T | 4.73% | |
| 9 | AVTEAEROVATE THERAPEUTICS INC | 2,201,274 | $29.9T | 4.40% | |
| 10 | —Icosavax, Inc. | 3,703,704 | $28.7T | 4.23% | |
| 11 | CMPSCOMPASS PATHWAYS PLC | 3,858,000 | $28.5T | 4.20% | |
| 12 | VTYXVENTYX BIOSCIENCES, INC | 815,724 | $28.3T | 4.17% | |
| 13 | TYRATYRA BIOSCIENCES INC | 1,989,103 | $27.4T | 4.03% | |
| 14 | MDGLMADRIGAL PHARMACEUTICALS INC | 179,917 | $26.3T | 3.87% | |
| 15 | SLNSILENCE THERAPEUTICS PLC | 2,104,875 | $20.7T | 3.04% | |
| 16 | TARSTARSUS PHARMACEUTICALS, INC. | 1,142,857 | $20.3T | 2.99% | |
| 17 | —RAYZEBIO, INC. | 869,908 | $19.3T | 2.84% | |
| 18 | DYNDYNE THERAPEUTICS, INC | 1,650,150 | $14.8T | 2.18% | |
| 19 | CNTACENTESSA PHARMACEUTICALS PLC | 2,040,816 | $13.2T | 1.94% | |
| 20 | KURAKURA ONCOLOGY INC | 1,423,642 | $13.0T | 1.91% | |
| 21 | IMVTIMMUNOVANT, INC | 334,853 | $12.9T | 1.89% | |
| 22 | TRDAENTRADA THERAPEUTICS INC | 584,955 | $9.2T | 1.36% | |
| 23 | GRCLGRACELL BIOTECHNOLOGIES INC. | 3,038,889 | $8.8T | 1.29% | |
| 24 | CABACABALETTA BIO, INC | 486,795 | $7.4T | 1.09% | |
| 25 | MRUSMERUS N.V. | 300,000 | $7.1T | 1.04% | |
| 26 | CCCCC4 THERAPEUTICS, INC. | 1,276,574 | $2.4T | 0.35% |